Amneal Pharmaceuticals Inc. (AMRX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Amneal Pharmaceuticals Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Amneal Pharmaceuticals Inc. (AMRX) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $7.5B. It trades at $21.14, down 1.40% today, at 46.9 times earnings. Its overall quality score is 45 out of 100, ranked against the whole US market. 6 analysts' average target of $23.33 implies +10.4% from today's price. Kronos AI's 30-day forecast is −22.1% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $23.33 |
| Low – high | $20.00 – $27.00 |
| Analysts | 6 |
| Upside to average | +10.4% |
Kronos AI 30-day forecast
| Expected close | $16.71 (−22.1%) |
| Likely range | −25.5% … −17.5% |
| As of | 2026-10-27 |
Quality scores
| Profitability | 58 |
| Solvency | 17 |
| Growth | 61 |
| Overall | 45 |
| P/E | 46.9 |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Halal Health Care stocks · Zakat calculator · Purification calculator